Given the strong links between hepatobiliary inflammation and the presence of IBD, these findings when taken together with our previously published data, support a role of CCR9/CCL25 interactions in driving recruitment of mucosal effector cells to the gut as well as liver in patients with ulcerative colitis. Here, CCL25 is linked to inflammatory bowel disease.